Screener
Vaxcyte, Inc. PCVX UNITED STATES — PP&E (Net)
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Vaxcyte, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001649094-26-000017
Our long-lived assets are based in the United States and Switzerland. Long-lived assets are comprised of property and equipment. As of March 31, 2026 and December 31, 2025, property and equipment based in the United States was $41.3 million and $39.7 million, respectively. As of March 31, 2026 and December 31, 2025, property and equipment based in Switzerland was $219.4 million and $217.7 million, respectively.
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Vaxcyte, Inc.'s UNITED STATES — PP&E (net)?
- Vaxcyte, Inc. (PCVX) reported UNITED STATES — PP&E (net) of $41.3M in Q1 2026.
- How has Vaxcyte, Inc.'s UNITED STATES — PP&E (net) changed year-over-year?
- Vaxcyte, Inc.'s UNITED STATES — PP&E (net) increased by 2.0% year-over-year, from $40.5M to $41.3M.
- What does UNITED STATES — PP&E (net) mean?
- This metric represents the net book value of tangible long-term assets located within the United States, including laboratory equipment, manufacturing facilities, and leasehold improvements. It reflects the company's physical infrastructure investment required to support research, development, and clinical trial operations in its primary geographic market. Monitoring this balance helps investors assess the scale of capital expenditure dedicated to domestic operational capacity.
Ask your AI about Vaxcyte, Inc.'s united states — pp&e (net).
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude